A recent pan-cancer analysis across 33 cancer types further revealed that GALNT7 expression had either a positive or negative impact on prognosis and tumor immunophenotypes, correlating with immune-related genes, immune-inhibitory genes, and immune cell infiltration (41). This evidence concerns the gene GALNT7 and cancer.